The eye-care company Alcon Research has entered into licensing and purchase option agreements with Potentia Pharmaceuticals to develop Potentia's leading drug candidate — a complement pathway ...

Mannan-binding lectin (MBL), M-, L- and H-ficolin recognize microorganisms and activate the complement system via MBL-associated serine proteases (MASPs). We investigated lectin pathway cord blood ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant ...

Annexon Biosciences (ANNX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ...

A new study has developed an innovative approach to combat antibiotic-resistant bacteria by tagging them with a chimeric agent that activates the immune system towards them.